|
PDHB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.353600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.624000E-02 |
| Normal-vs-Stage2 |
1.547850E-01 |
| Normal-vs-Stage3 |
1.602070E-04 |
| Normal-vs-Stage4 |
2.72050000005297E-06 |
| Stage1-vs-Stage2 |
2.876300E-03 |
| Stage1-vs-Stage3 |
5.217600E-03 |
| Stage1-vs-Stage4 |
1.369910E-04 |
| Stage2-vs-Stage3 |
7.96230000000842E-05 |
| Stage2-vs-Stage4 |
2.39469999996356E-06 |
| Stage3-vs-Stage4 |
2.092000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.217400E-04 |
| Normal-vs-AfricanAmerican |
8.402300E-03 |
| Normal-vs-Asian |
4.146800E-01 |
| Caucasian-vs-AfricanAmerican |
5.772800E-01 |
| Caucasian-vs-Asian |
6.846400E-02 |
| AfricanAmerican-vs-Asian |
7.187600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.264050E-02 |
| Normal-vs-Female |
2.738000E-02 |
| Male-vs-Female |
4.299800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.297700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.819300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.184240E-01 |
| Normal-vs-Age(81-100Yrs) |
5.915600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.743400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.721600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.130000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.875200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.754400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.643000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.283350E-01 |
| Classical-VS-Follicular |
2.978200E-04 |
| Classical-VS-Other |
7.847000E-01 |
| Classical-VS-Normal |
3.002400E-03 |
| Tall-VS-Follicular |
5.82209999999694E-05 |
| Tall-VS-Other |
6.115200E-01 |
| Tall-VS-Normal |
4.388600E-04 |
| Follicular-VS-Other |
1.813010E-01 |
| Follicular-VS-Normal |
2.814400E-01 |
| Other-VS-Normal |
1.470610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.364790E-01 |
| Normal-vs-N1 |
5.54520000000114E-05 |
| N0-vs-N1 |
8.197500E-04 |
|
|
